Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anti-VEGF compounds in the treatment of neovascular age related macular degeneration.
Campa C, Harding SP. Campa C, et al. Curr Drug Targets. 2011 Feb;12(2):173-81. doi: 10.2174/138945011794182674. Curr Drug Targets. 2011. PMID: 20887245 Review.
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.
Campa C, Costagliola C, Incorvaia C, Sheridan C, Semeraro F, De Nadai K, Sebastiani A, Parmeggiani F. Campa C, et al. Mediators Inflamm. 2010;2010:546826. doi: 10.1155/2010/546826. Epub 2010 Aug 25. Mediators Inflamm. 2010. PMID: 20871825 Free PMC article. Review.
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C. Incorvaia C, et al. Among authors: campa c. Retina. 2008 Feb;28(2):289-97. doi: 10.1097/IAE.0b013e31813ffe90. Retina. 2008. PMID: 18301052
Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation.
Campa C, Harding SP, Pearce IA, Beare NA, Briggs MC, Heimann H. Campa C, et al. Eye (Lond). 2010 Oct;24(10):1585-9. doi: 10.1038/eye.2010.88. Epub 2010 Jun 11. Eye (Lond). 2010. PMID: 20539314
Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy.
Kumar A, Sahni JN, Stangos AN, Campa C, Harding SP. Kumar A, et al. Among authors: campa c. Br J Ophthalmol. 2011 Apr;95(4):530-3. doi: 10.1136/bjo.2009.171868. Epub 2010 Oct 11. Br J Ophthalmol. 2011. PMID: 20937739
Early multifocal electroretinogram findings during intravitreal ranibizumab treatment for neovascular age-related macular degeneration.
Campa C, Hagan R, Sahni JN, Brown MC, Beare NA, Heimann H, Harding SP. Campa C, et al. Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3446-51. doi: 10.1167/iovs.10-6588. Invest Ophthalmol Vis Sci. 2011. PMID: 21357390
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration.
Parmeggiani F, Costagliola C, Gemmati D, D'Angelo S, Perri P, Campa C, Catozzi L, Federici F, Sebastiani A, Incorvaia C. Parmeggiani F, et al. Among authors: campa c. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3100-6. doi: 10.1167/iovs.07-1654. Epub 2008 Mar 31. Invest Ophthalmol Vis Sci. 2008. PMID: 18378576
Anti-VEGF Therapy for Retinal Vein Occlusions.
Campa C, Alivernini G, Bolletta E, Parodi MB, Perri P. Campa C, et al. Curr Drug Targets. 2016;17(3):328-36. doi: 10.2174/1573399811666150615151324. Curr Drug Targets. 2016. PMID: 26073857 Review.
Effect of VEGF and anti-VEGF compounds on retinal pigment epithelium permeability: an in vitro study.
Campa C. Campa C. Eur J Ophthalmol. 2013 Sep-Oct;23(5):690-6. doi: 10.5301/ejo.5000248. Epub 2013 Mar 28. Eur J Ophthalmol. 2013. PMID: 23539459
Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.
Campa C, Kasman I, Ye W, Lee WP, Fuh G, Ferrara N. Campa C, et al. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1178-83. doi: 10.1167/iovs.07-1194. Invest Ophthalmol Vis Sci. 2008. PMID: 18326747
127 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback